PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions

Viral; Infection, Coxsackie(Virus)

Interventions

BIOLOGICAL

PRV-101

Coxsackie Virus B vaccine

OTHER

Placebo

Trial Locations (1)

Clinical Research Services Turku (CRST) Oy, Turku

All Listed Sponsors

lead

Provention Bio, Inc.

INDUSTRY

NCT04690426 - PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers | Biotech Hunter | Biotech Hunter